Cadaverine Tartrate

Cadaverine Tartrate

SCHEMBL6355357

O=C([O-])C(O)C(O)C(=O)[O-].[Pd+2]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3BCHECHRM1CHRM2CHRM3CHRM4CHRNA3CHRNA4CHRNB2CHRNB4ESR1ESR2GABRA1GABRB1GABRG2GBA1GHSRHRH1HTR1DHTR2AMAOBOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8UGCGrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.47
LMNA P02545 2/20 0.43
CA4 P22748 3/20 0.40
CYP3A4 P08684 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
TP53 P04637 1/20 0.35
CA1 P00915 3/20 0.33
FAHD1 Q6P587 1/20 0.33
NFKB1 P19838 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
SLC22A6 Q4U2R8 1/20 0.32
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cadaverine Tartrate SCHEMBL28237556 0.96 TSHR (0.44) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL3591252 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL5141545 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL813951 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL119095 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL23855755 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL223358 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL16527654 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL372570 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1
Cadaverine Tartrate SCHEMBL1985645 0.92 TSHR (0.47) TSHRLMNACA4CYP3A4TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013122828-A1 FILM WITH ABSORBING COATING MORGAN ADHESIVES COMPANY (US) 2013-08-22 WO claimed
US-20130209312-A1 Film With Absorbing Coating MORGAN ADHESIVES COMPANY (US) 2013-08-15 US claimed
EP-2626379-A1 Film with absorbing coating Morgan Adhesives Company (US) 2013-08-14 EP claimed
US-12605697-B1 Palladium/palladium oxide/calcium silicate/graphitic carbon nitride nanocomposite material IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) 2026-04-21 US disclosed
CN-113461838-A Method for hydrogenation and catalyst separation of nitrile rubber by using ionic liquid 中国科学院兰州化学物理研究所 2021-10-01 CN disclosed
CN-106694010-B A kind of catalyst and preparation method thereof for half Hydrogenation enol of alkynol 重庆建峰工业集团有限公司 2018-08-28 CN disclosed
CN-106748658-A A kind of method that alkynol semihydrogenation prepares enol 重庆建峰工业集团有限公司 2017-05-31 CN disclosed
CN-106694010-A Catalyst for preparation of enol through alkynol semi-hydrogenation and preparation method of catalyst 重庆建峰工业集团有限公司 2017-05-24 CN disclosed
WO-2013122828-A1 FILM WITH ABSORBING COATING MORGAN ADHESIVES COMPANY (US) 2013-08-22 WO disclosed
US-20130209312-A1 Film With Absorbing Coating MORGAN ADHESIVES COMPANY (US) 2013-08-15 US disclosed
EP-2626379-A1 Film with absorbing coating Morgan Adhesives Company (US) 2013-08-14 EP disclosed
EP-0263564-A1 Catalyst compositions and olefin/CO-copolymerization process SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-04-13 EP disclosed
CN-87106659-A The method for preparing polymkeric substance 1988-04-13 CN disclosed
EP-0262745-A2 Polymer preparation SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-04-06 EP disclosed
US-4510293-A PALLADIUM SALT OF A CARBOXYLIC ACID Nippon Zenn Co. Ltd. (JP) 1985-04-09 US disclosed
US-4320091-A SEPARATION OF DILVENT FROM FIRST STAGE-PRODUCT SATURATED DINITRIES; BY-PRODUCT INHIBITION PHILLIPS PETROLEUM COMPANY (US) 1982-03-16 US disclosed
US-4263228-A Two stage catalytic hydrogenation of olefinically unsaturated dinitriles PHILLIPS PETROLEUM COMPANY (US) 1981-04-21 US disclosed
US-4216169-A WITH PALLADIUM AND COBALT CATALYSTS PHILLIPS PETROLEUM COMPANY (US) 1980-08-05 US disclosed
US-4180480-A Catalytically active compositions from precious metal complexes MCGEAN CHEMICAL COMPANY, INC. (US) 1979-12-25 US disclosed
US-4130484-A Purification process PHILLIPS PETROLEUM COMPANY (US) 1978-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12605697-B1 Palladium/palladium oxide/calcium silicate/graphitic carbon nitride nanocomposite material PDCD4, PDCD1LG2, CD274 TSHR 3182/4885LMNA 737/4885CA4 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.